Author:
Meltzer Andrew C.,Wargowsky Richard S.,Moran Seamus,Jordan Tristan,Toma Ian,Jepson Tisha,Shu Shiyu,Ma Yan,McCaffrey Timothy A.
Abstract
AbstractAbdominal pain represents greater than 20% of US Emergency Department (ED) visits due to a wide range of illnesses. There are currently no reliable blood biomarkers to predict serious outcomes in patients with abdominal pain. Our previous studies have identified three mRNA transcripts related to innate immune activation: alkaline phosphatase (ALPL), interleukin-8 receptor-β (IL8RB), and defensin-1 (DEFA1) as promising candidates to detect an intra-abdominal infection. The objective of this study was to evaluate the accuracy of these mRNA biomarkers to predict likely infection, hospitalization and surgery in Emergency Department patients with undifferentiated abdominal pain. We prospectively enrolled Emergency Department patients with undifferentiated abdominal pain who received an abdominal CT scan as part of their evaluation. Clinical outcomes were abstracted from the CT scan and medical records. mRNA biomarker levels were calculated independent of the clinical outcomes and their accuracy was assessed to predict infectious diagnoses, surgery and hospital admission. 89 patients were enrolled; 21 underwent surgery; 47 underwent hospital admission; and, no deaths were observed within 30 days. In identifying which cases were likely infectious, mRNA biomarkers’ AUC values were: ALPL, 0.83; DEFA1 0.51; IL8RB, 0.74; and ALPL + IL8RB, 0.79. In predicting which Emergency Department patients would receive surgery, the AUC values were: ALPL, 0.75; DEFA1, 0.58; IL8RB, 0.75; and ALPL + IL8RB, 0.76. In predicting hospital admission, the AUC values were: ALPL, 0.78; DEFA1, 0.52; IL8RB, 0.74; and, ALPL + IL8RB, 0.77. For predicting surgery, ALPL + IL8RB’s positive likelihood ratio (LR) was 3.97; negative LR (NLR) was 0.70. For predicting hospital admission, the same marker’s positive LR was 2.80 with an NLR of 0.45. Where the primary cause for admission was a potentially infectious disorder, 33 of 34 cases (97%) had positive RNA scores. In a pragmatic, prospective diagnostic accuracy trial in Emergency Department patients with undifferentiated abdominal pain, mRNA biomarkers showed good accuracy to identify patients with potential infection, as well as those needing surgery or hospital admission.
Funder
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Meltzer, A. C., Pines, J. M., Richards, L. M., Mullins, P. & Mazer-Amirshahi, M. US emergency department visits for adults with abdominal and pelvic pain (2007–13): Trends in demographics, resource utilization and medication usage. Am. J. Emerg. Med. 35, 1966–1969 (2017).
2. National Hospital Ambulatory Medical Care Survey: 2018 Emergency Department Summary Tables. Centers for Disease Control and Prevention National Center for Health Statistics (2018). https://www.cdc.gov/nchs/data/nhamcs/web_tables/2018-ed-web-tables-508.pdf. Accessed July 28, 2021.
3. Oliveira, J. E. et al. Depression and anxiety screening in emergency department patients with recurrent abdominal pain: An evidence synthesis for a clinical practice guideline. Acad. Emerg. Med. https://doi.org/10.1111/acem.14394 (2021).
4. Breidthardt, T. et al. Inflammatory biomarkers and clinical judgment in the emergency diagnosis of urgent abdominal pain. Clin. Chem. 65(2), 302–312. https://doi.org/10.1373/clinchem.2018.296491 (2019).
5. Arbutina, D. D. et al. Significance of biomarkers in early diagnosis of abdominal sepsis. Chirurgia (Bucur). 117(1), 30–36. https://doi.org/10.21614/chirurgia.2660 (2022).